--- title: "Seconds-Count.org Physicians’ Blog — January 2008" url: https://seconds-count.org/blog/ description: "the January 2008 monthly archive of the Seconds-Count.org Physicians' Blog, with four dated posts." --- # Seconds-Count.org Physicians’ Blog — January 2008 [‹ Return to the homepage](https://seconds-count.org/) In the source’s own words Seconds-Count.org Physicians’ Blog — 2008 — January: the monthly archive page from the site backup, carrying four posts. 1/31/2008 ## [First, Do No Harm: Misleading Media Reports Are Detrimental to Cardiovascular Patient Care](https://seconds-count.org/blog/first-do-no-harm-misleading-media-reports/) Posted under General by admin on Thursday, January 31, 2008 · 4 comments It’s one thing for media reports to inadvertently spread confusion based on highly scientific, complex reports and conflicting experts. It’s quite another to spread fear and distrust based on lopsided reporting derived upon unsubstantiated and misleading information. [Read the archived post](https://seconds-count.org/blog/first-do-no-harm-misleading-media-reports/) 1/25/2008 ## [Understanding “Off-Label”](https://seconds-count.org/blog/understanding-off-label/) Posted under General by admin on Friday, January 25, 2008 · No comment A story in the *New York Times* on Jan. 21 about an upcoming article in the *American Journal of Therapeutics* on the use of peripheral stents – stents used in the arms and legs, primarily – was alarming to some patients who have received stents in their peripheral arteries. The story talked about “off-label” use of peripheral stents. If you are patient who has received a stent and wonder if it was “off-label,” the first thing you should know is that you do not need to be alarmed or afraid. Following the *New York Times* story, many physicians like me received numerous calls from patients wondering if “off-label” meant the stents they received were unsafe, or even illegal. I’d like to explain what “off-label” means and why doctors often choose to use medications, devices, and treatments “off-label” to achieve the best outcomes for our patients. [Read the archived post](https://seconds-count.org/blog/understanding-off-label/) 1/25/2008 ## [Stent Research: More Data, But What Does It Mean for You?](https://seconds-count.org/blog/stent-research-more-data/) Posted under General by admin on Friday, January 25, 2008 · No comment If you are a cardiovascular patient, you can rest assured that there is no lack of research being done on the various therapies available to you! Just this week, two studies focused on drug-eluting stents and an accompanying commentary piece on the findings appeared in the New England Journal of Medicine. Like other recent cardiovascular research, these two studies have received a good amount of media coverage, and justifiably so – cardiovascular disease is the number one cause of death in America and the treatments used in these studies are performed on millions of our patients each year. Just as patients are always on the look-out for news related to their condition, physicians are always eager to have solid research to help us provide the best possible patient care. [Read the archived post](https://seconds-count.org/blog/stent-research-more-data/) 1/17/2008 ## [Vytorin and Other Headlines: What’s a Patient to Do?](https://seconds-count.org/blog/vytorin-and-other-headlines/) Posted under General by admin on Thursday, January 17, 2008 · 3 comments The recent news about a cholesterol-lowering drug called Vytorin is a good case study for how you, as a patient, should respond to what you read or hear in the news about your prescribed medical therapy. [Read the archived post](https://seconds-count.org/blog/vytorin-and-other-headlines/) [‹ Return to the homepage](https://seconds-count.org/) ## About this archive These pages reproduce what survived in the site backup of seconds-count.org: one 2007 homepage and one January 2008 monthly archive from the Physicians’ Blog. [Read the full archive note](https://seconds-count.org/about/) ## Source and dating Homepage source: `index.html`, headlines dated 8/21/2007 to 10/28/2007. Blog source: `blog/index.html`, four posts dated 1/17/2008 to 1/31/2008. Reviewed on this archive: 2007–2008 text, reproduced unchanged. ## Blog categories - [Cardiac CT](https://seconds-count.org/topics/#cardiac-ct) - [Children](https://seconds-count.org/topics/#children) - [General](https://seconds-count.org/topics/#general) - [Heart Disease](https://seconds-count.org/topics/#heart-disease) - [Heparin](https://seconds-count.org/topics/#heparin) - [Minimally Invasive](https://seconds-count.org/topics/#minimally-invasive) - [Statins](https://seconds-count.org/topics/#statins) - [Stents](https://seconds-count.org/topics/#stents) - [Stroke](https://seconds-count.org/topics/#stroke) - [Women](https://seconds-count.org/topics/#women) ## Blog archive months archive labels; only January 2008 survived with post content. - November 2008 - October 2008 - September 2008 - August 2008 - July 2008 - June 2008 - May 2008 - April 2008 - March 2008 - February 2008 - [January 2008](https://seconds-count.org/blog/) - December 2007 - November 2007 - October 2007 ## Editorial and source policy Every line of text on this site is reproduced from the 2007–2008 files. Nothing has been added, updated, expanded or re-worded. This site is a historical archive of pages published at seconds-count.org in 2007 and 2008. It is not affiliated with, endorsed by, or operated by the Society for Cardiovascular Angiography and Interventions or any other medical society, certifying board, hospital or health authority. The reference to SCAI above is part of the original 2007 homepage text and describes the site as it stood then, not any current relationship. ## Article register [01**15Five vs HeyRamp: Performance Reviews Compared**Oct 16, 2026](https://seconds-count.org/15five-vs-heyramp-performance-reviews-compared/) [02**How to Choose the Best Tools for WhatsApp Lead Generation in 2026**Oct 06, 2026](https://seconds-count.org/how-to-choose-the-best-tools-for-whatsapp-lead-generation-in-2026/) [03**Find Medical Coding and Billing Programs Near You**Sep 14, 2026](https://seconds-count.org/medical-coding-and-billing-near-me/) [04**Real Time Reporting Automation Software Pricing: What You Should Expect to Pay**Sep 10, 2026](https://seconds-count.org/real-time-reporting-automation-software-pricing-what-you-should-expect-to-pay/) [05**How to Choose the Right WhatsApp Business API Platforms for Multi-Channel Support**Aug 31, 2026](https://seconds-count.org/how-to-choose-the-right-whatsapp-business-api-platforms-for-multi-channel-support/) [06**Why Is Medicai the Best for Deep IT Integration?**Aug 10, 2026](https://seconds-count.org/why-is-medicai-the-best-for-deep-it-integration/) [07**PostDICOM vs Medicai for Vendor-Neutral Archives**Aug 08, 2026](https://seconds-count.org/postdicom-vs-medicai-for-vendor-neutral-archives/) [08**The 4 Best Enterprise Imaging Platforms for Cloud-Based Medical Imaging Solutions**Aug 07, 2026](https://seconds-count.org/the-4-best-enterprise-imaging-platforms-for-cloud-based-medical-imaging-solutions/) [09**Why Is JoinJosie the Best for Mail-Order Prescriptions?**Aug 05, 2026](https://seconds-count.org/why-is-joinjosie-the-best-for-mail-order-prescriptions/) More [10**Why Is JoinJosie the Best for Subscription Basis For Medication?**Jul 31, 2026](https://seconds-count.org/why-is-joinjosie-the-best-for-subscription-basis-for-medication/) [11**Why Is JoinJosie the Best for Digital-first Approach?**Jul 31, 2026](https://seconds-count.org/why-is-joinjosie-the-best-for-digital-first-approach/) [12**Who's the Best for Mobile Access: Tricefy vs Medicai**Jul 30, 2026](https://seconds-count.org/who-s-the-best-for-mobile-access-tricefy-vs-medicai/) [13**Top 3 Alternatives of IntelePACS for Highly Scalable System**Jul 29, 2026](https://seconds-count.org/top-3-alternatives-of-intelepacs-for-highly-scalable-system/) [14**10 WhatsApp Marketing Software Solutions With Marketing Analytics**Jun 21, 2026](https://seconds-count.org/10-whatsapp-marketing-software-solutions-with-marketing-analytics/)